c-Myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases

Journal of Cellular Biochemistry

Volumn 70, Issue 4, 1998, Pages 528-542

  Alexandrow, Mark G ^a   Moses, Harold L ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

c Myc; Cdk; Cdk inhibitors; Cell cycle; Keratinocytes

Indexed keywords

CYCLIN DEPENDENT KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION REGULATION; HORMONAL REGULATION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPIDERMAL GROWTH FACTOR; G1 PHASE; GENE EXPRESSION REGULATION; KERATINOCYTES; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; PROTAMINE KINASE; PROTO-ONCOGENE PROTEINS C-MYC; RATS; S PHASE; THYMIDINE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0032531275     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980915)70:4<528::AID-JCB9>3.0.CO;2-L     Document Type: Article

References (73)

1. Alexandrow MG, Kawabata M, Aakre M, Moses HL (1995): Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor §1. Proc Natl Acad Sci USA 92:3239-3243.
2. Alitalo K, Koskinen P, Makela TP, Saksela K, Sistonen L, Winqvist R (1987): Myc oncogenes: Activation and amplification. Biochim Biophys Acta 907:1-32.
3. Amati B, Littlewood TD, Evan GI, Land H (1993): The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12:5083-5087.
4. Barrett JF, Lewis BC, Hoang AT, Alvarez RJ, Jr., Dang CV (1995): Cyclin A links c-Myc to adhesion-independent cell proliferation. J Biol Chem 270:15923-15925.
5. Bello-Fernandez C, Cleveland JL (1992): c-myc Transactivates the ornithine decarboxylase gene. Curr Top Microbiol Immunol 182:445-452.
6. Benvenisty N, Leder A, Kuo A, Leder P (1992): An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev 6:2513-2523.
7. Bishop JM, Eilers M, Katzen AL, Kornberg T, Ramsay G, Schirm S (1991): MYB and MYC in the cell cycle. Cold Spring Harbor Symp Quant Biol 56:99-107.
8. Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992): Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
9. Braselmann S, Graninger P, Busslinger M (1993): A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 90:1657-1661.
10. Brush GS, Anderson CW, Kelly TJ (1994): The DNA-activated protein kinase is required for the phosphorylation of replication protein A during simian virus 40 DNA replication. Proc Natl Acad Sci USA 91:12520-12524.
11. Cao L, Faha B, Dembski M, Tsai LH, Harlow E, Dyson N (1992): Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179.
12. Dang CV (1991): c-Myc oncoprotein function. Biochim Biophys Acta 1072:103-113.
13. Dunphy WG, Kumagai A (1991): The cdc25 protein contains an intrinsic phosphatase activity. Cell 67:189-196.
14. Dutta A, Din S, Brill SJ, Stillman B (1991): Phosphorylation of replication protein A: A role for cdc2 kinase in G1/S regulation. Cold Spring Harbor Symp Quant Biol LVI: 315-324.
15. Dutta A, Stillman B (1992): Cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. EMBO J 11:2189-2199.
16. Dynlacht BD, Flores O, Lees JA, Harlow E (1994): Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev 8:1772-1786.
17. Eilers M, Picard D, Yamamoto KR, Bishop JM (1989): Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340: 66-68.
18. Eilers M, Schirm S, Bishop JM (1991): The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J 10:133-141.
19. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992): Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
20. Fang F, Newport JW (1993): Distinct roles of cdk2 and cdc2 in RP-A phosphorylation during the cell cycle. J Cell Science 106:983-994.
21. Fisher F, Crouch DH, Jayaraman P-S, Clark W, Gillespie DAF, Coding CR (1993): Transcription activation by Myc and Max: Flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J 12:5075-5082.
22. Fotedar R, Roberts JM (1992): Cell cycle regulated phosphorylation of RPA-32 occurs within the replication initiation complex. EMBO J 11:2177-2187.
23. Gai X, Rizzo M-G, Valpreda S, Baserga R (1990): Regulation of c-myc mRNA levels by insulin or platelet-poor plasma. Oncogene Res 5:111-120.
24. Galaktionov K, Chen X, Beach D (1996): Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
25. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW (1991): cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67:197-211.
26. Gibson AW, Cheng T, Johnston RN (1995): Apoptosis induced by c-Myc overexpression is dependent on growth conditions. Exp Cell Res 218:351-358.
27. Greenberg ME, Ziff EB (1984): Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
28. Hanson KD, Shichiri M, Follansbee MR, Sedivy JM (1994): Effects of c-myc expression on cell cycle progression. Mol Cell Biol 14:5748-5755.
29. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV (1994): Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91:6875-6879.
30. Jansen-Dürr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M (1993): Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 90:3685-3689.
31. Karn J, Watson JV, Lowe AD, Green SM, Vedeckis W (1989): Regulation of cell cycle duration by c-myc levels. Oncogene 4:773-787.
32. Kazumoto K, Tamura M, Hoshino H, Yuasa Y (1990): Enhanced expression of the sis and c-myc oncogenes in human meningiomas. J Neurosurg 72:786-791.
33. Kelly K, Cochran BH, Stiles CD, Leder P (1983): Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
34. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM (1996): Inhibition of cyclin D-Cdk4/Cdk6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93:4350-4354.
35. Koskinen PJ, Makela TP, Vastrik I, Alitalo K (1993): Myc amplification: Regulation of Myc function. Clin Chim Acta 217:57-62.
36. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR (1995): E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 69:2491-2500.
37. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Jr., Livingston DM (1994): Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
38. Lees E, Faha B, Dulic V, Reed SI, Harlow E (1992): Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1885.
39. Longhese MP, Plevani P, Lucchini G (1994): Replication factor A is required in vivo for DNA replication, repair, and recombination. Mol Cell Biol 14:7884-7890.
40. Marcu KB, Bossone SA, Patel AJ (1992): Myc function and regulation. Ann Rev Biochem 61:809-860.
41. Meichle A, Philipp A, Eilers M (1992): The functions of Myc proteins. Biochim Biophys Acta 1114:129-146.
42. Milner AE, Grand RJA, Waters CM, Gregory CD (1993): Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 8:3385-3391.
43. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol 15:2527-2535.
44. Münger K, Pietenpol JA, Pittelkow MR, Holt JT, Moses HL (1992): Transforming growth factor §1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ 3:291-298.
45. Packham G, Cleveland JL (1994): Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 14:5741-5747.
46. Pan Z-Q, Amin AA, Gibbs E, Niu H, Hurwitz J (1994): Phosphorylation of the p34 subunit of human single-stranded-DNA-binding protein in cyclin A-activated G1 extracts is catalyzed by cdk-cyclin A complex and DNA-dependent protein kinase. Proc Natl Acad Sci USA 91: 8343-8347.
47. Peña A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ (1993): Regulation of human ornithine decarboxylase expression by the c-Myc/Max protein complex. J Biol Chem 268:27277-27285.
48. Pena A, Wu SJ, Hickok NJ, Soprano DR, Soprano KJ (1995): Regulation of human ornithine decarboxylase expression following prolonged quiescence: Role for the c-Myc/Max protein complex. J Cell Physiol 162:234-245.
49. Philipp A, Schneider A, Väsrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M (1994): Repression of cyclin D1: A novel function of MYC. Mol Cell Biol 14:4032-4043.
50. Pietenpol JA, Holt JT, Stein RW, Moses HL (1990): Transforming growth factor β1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87:3758-3762.
51. 1 phase in rodent fibroblasts. Genes Dev 7:1559-1571.
52. Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J, Busslinger M, Beug H (1992): Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103-1116.
53. Roussel MF, Theodoras AM, Pagano M, Sherr CJ (1995): Rescue of defective mitogenic signaling by D-type cyclins. Proc Natl Acad Sci USA 92:6837-6841.
54. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang X-F, Nevins JR (1995): Expression of the E2F1 transcription factor overcomes type § transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 92: 483-487.
55. Selvakumaran M, Lin H-K, Tjin Tham Sjin R, Reed JC, Liebermann DA, Huffman B (1994): The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14:2352-2360.
56. Shan B, Lee W-H (1994): Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166-8173.
57. Shan B, Durfee T, Lee W-H (1996): Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci USA 93:679-684.
58. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992): Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214.
59. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T (1992): IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc. Cell 70:57-67.
60. Shichiri M, Hanson KD, Sedivy JM (1993): Effects of c-myc expression on proliferation, quiescence, and the GO to G1 transition in nontransformed cells. Cell Growth Differ 4:93-104.
61. Shipley GD, Tucker RF, Moses HL (1985): Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci USA 82:4147-4151.
62. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T (1992): The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
63. Solomon DLC, Philipp A, Land H, Eilers M (1995): Expression of cyclin D1 mRNAis not upregulated by Myc in rat fibroblasts. Oncogene 11:1893-1897.
64. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M (1995): Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J 14:4814-4826.
65. Stuhlmann H, Cone R, Mulligan RC, Jaenisch R (1984): Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector. Proc Natl Acad Sci USA 81:7151-7155.
66. Superti-Furga G, Bergers G, Picard D, Busslinger M (1991): Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. Proc Natl Acad Sci USA 88:5114-5118.
67. Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K, Miyaki M (1989): Establishment of a human malignant meingioma cell line with amplified c-myc oncogene. Cancer 64:2243-2249.
68. Tavtigian SV, Zabludoff SD, Wold BJ (1994): Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol Biol Cell 5:375-388.
69. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B (1996): Growth-arrest by the cyclin-dependent kinase inhibitor p27 Kip1 is abrogated by c-Myc. EMBO J 15: 6595-6604.
70. waf1/cip1. Genes Dev 8:2817-2830.
71. Weissman BE, Aaronson SA (1983): BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines. Cell 32:599-606.
72. Wu C-L, Zukerberg LR, Ngwu C, Harlow E, Lees JA (1995): In vivo association of E2F and DP family proteins. Mol Cell Biol 15:2536-2546.
73. Xu M, Sheppard K-A, Peng C-Y, Yee AS, Piwnica-Worms H (1994): Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14:8420-8431.